| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Department of Pathology, Loyola University Medical Center (A.Sl., B.R., J.C., M.D.), Maywood, Illinois 60153; Hitachi Instruments, Inc. (A.Sz.), Naperville, Illinois; and the Department of Internal Medicine, Southern Illinois University (J.W.), Springfield, Illinois
Address all correspondence and requests for reprints to: Andrzej Slominski, M.D., Ph.D., Department of Pathology, Loyola University Medical Center, 2160 First South Avenue, Maywood, Illinois 60153. E-mail: aslomin{at}wpo.it.luc.edu
Since the skin produces POMC peptides, in the present work we investigated local production of urocortin, a peptide related to CRH, the normal endogenous stimulant for POMC. Urocortin immunoreactivity was detected by direct RIA in extracts of human skin, mouse skin (C57BL-6 strain), cultured cells from established lines of human melanoma and squamous cell carcinoma, human keratinocytes (HaCaT), and hamster melanomas. Addition of a reverse phase high performance liquid chromatography step before the RIA confirmed the presence of urocortin, as the immunoreactivity eluted at the same retention time as urocortin standard in extracts from HaCaT keratinocytes and mouse skin. Using the tandem technique of liquid chromatography-mass spectrometry, we identified a peptide with the same mass and retention time as the urocortin standard in human skin extracts. The urocortin antigen could be immunolocalized to normal keratinocytes of the epidermis and hair follicle, epithelium of sweat and sebaceous glands, dermal skeletal muscle, and nevocytes; it was also detected in melanoma and basal cell carcinoma cells. RT-PCR amplification of ribonucleic acid from human skin, cultured keratinocytes, and melanoma cells showed a 145-kb fragment from the coding region of exon 2 of the urocortin gene in all of the tested sources. Lastly, sequencing of the amplified fragment confirmed 100% homology with the known sequence of the urocortin gene. In conclusion, we now demonstrate that human skin and mouse skin as well as cultured keratinocytes and melanoma cells exhibit functional expression of the urocortin gene with actual production of urocortin peptide.
This article has been cited by other articles:
![]() |
T. Kimura, T. Amano, H. Uehara, H. Ariga, T. Ishida, A. Torii, H. Tajiri, K. Matsueda, and S. Yamato Urocortin I is present in the enteric nervous system and exerts an excitatory effect via cholinergic and serotonergic pathways in the rat colon Am J Physiol Gastrointest Liver Physiol, October 1, 2007; 293(4): G903 - G910. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Roosterman, T. Goerge, S. W. Schneider, N. W. Bunnett, and M. Steinhoff Neuronal control of skin function: the skin as a neuroimmunoendocrine organ. Physiol Rev, October 1, 2006; 86(4): 1309 - 1379. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kauser, A. Slominski, E. T. Wei, and D. J. Tobin Modulation of the human hair follicle pigmentary unit by corticotropin-releasing hormone and urocortin peptides FASEB J, May 1, 2006; 20(7): 882 - 895. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wu, Y. Xu, H. Zhou, J. Tao, and S. Li Expression of urocortin in rat lung and its effect on pulmonary vascular permeability. J. Endocrinol., April 1, 2006; 189(1): 167 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sashinami, K. Kageyama, T. Suda, and A. Nakane Urocortin 2 Suppresses Host Resistance to Listeria monocytogenes Infection via Up-Regulation of Interleukin-10 Endocrinology, November 1, 2005; 146(11): 5003 - 5011. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chen, A. Blount, J. Vaughan, B. Brar, and W. Vale Urocortin II Gene Is Highly Expressed in Mouse Skin and Skeletal Muscle Tissues: Localization, Basal Expression in Corticotropin-Releasing Factor Receptor (CRFR) 1- and CRFR2-Null Mice, and Regulation by Glucocorticoids Endocrinology, May 1, 2004; 145(5): 2445 - 2457. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Davis, C. J. Pemberton, T. G. Yandle, J. G. Lainchbury, M. T. Rademaker, M. G. Nicholls, C. M. Frampton, and A. M. Richards Urocortin-1 Infusion in Normal Humans J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1402 - 1409. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Slominski, A. Pisarchik, D. J. Tobin, J. E. Mazurkiewicz, and J. Wortsman Differential Expression of a Cutaneous Corticotropin-Releasing Hormone System Endocrinology, February 1, 2004; 145(2): 941 - 950. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Crompton, V. L. Clifton, A. T. Bisits, M. A. Read, R. Smith, and I. M. R. Wright Corticotropin-Releasing Hormone Causes Vasodilation in Human Skin via Mast Cell-Dependent Pathways J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5427 - 5432. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Wiesner, B. Roloff, K. Fechner, and A. Slominski Intracellular calcium measurements of single human skin cells after stimulation with corticotropin-releasing factor and urocortin using confocal laser scanning microscopy J. Cell Sci., April 1, 2003; 116(7): 1261 - 1268. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Zouboulis, H. Seltmann, N. Hiroi, W. Chen, M. Young, M. Oeff, W. A. Scherbaum, C. E. Orfanos, S. M. McCann, and S. R. Bornstein Corticotropin-releasing hormone: An autocrine hormone that promotes lipogenesis in human sebocytes PNAS, May 14, 2002; 99(10): 7148 - 7153. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kohno, Y. Kawahito, Y. Tsubouchi, A. Hashiramoto, R. Yamada, K.-i. Inoue, Y. Kusaka, T. Kubo, I. J. Elenkov, G. P. Chrousos, et al. Urocortin Expression in Synovium of Patients with Rheumatoid Arthritis and Osteoarthritis: Relation to Inflammatory Activity J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4344 - 4352. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. SLOMINSKI, J. WORTSMAN, A. PISARCHIK, B. ZBYTEK, E. A. LINTON, J. E. MAZURKIEWICZ, and E. T. WEI Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors FASEB J, August 1, 2001; 15(10): 1678 - 1693. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Slominski and J. Wortsman Neuroendocrinology of the Skin Endocr. Rev., October 1, 2000; 21(5): 457 - 487. [Abstract] [Full Text] |
||||
![]() |
A. Slominski, A. Szczesniewski, and J. Wortsman Liquid Chromatography-Mass Spectrometry Detection of Corticotropin-Releasing Hormone and Proopiomelanocortin-Derived Peptides in Human Skin J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3582 - 3588. [Abstract] [Full Text] |
||||
![]() |
A. Slominski, J. Wortsman, T. Luger, R. Paus, and S. Solomon Corticotropin Releasing Hormone and Proopiomelanocortin Involvement in the Cutaneous Response to Stress Physiol Rev, July 1, 2000; 80(3): 979 - 1020. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |